Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium

NCT05690698 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT05690698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05690698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium
Lead sponsor
Alexandria University
Phase
Phase 3
Overall status
Completed
Start date
April 9, 2023
Completion date
July 15, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperactive delirium